Ftse Mib
37.999,73
0,00%
DAX
22.567,14
-0,44%
S&P 500
5.521,52
-1,39%
NASDAQ
17.303,01
-1,96%
Bitcoin
82.082,11
1,29%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enanta Pharmaceuticals Inc (ENTA) Enanta Pharmaceuticals Inc (ENTA) Notizie

Enanta Pharmaceuticals Inc

ENTA
6,83
0,00 (0,00%)
14 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202523:05EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
14/2/202522:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202502:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/2/202522:05EDGAR2Form 8-K - Current report
10/2/202522:01BWEnanta Pharmaceuticals Reports Financial Results for its..
27/1/202522:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/1/202522:00EDGAR2Form DEF 14A - Other definitive proxy statements
22/1/202522:01EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
08/1/202513:00BWEnanta Pharmaceuticals to Present at the 43rd Annual J.P...
24/12/202413:00BWEnanta Pharmaceuticals to Appeal Ruling Related to ‘953..
10/12/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202414:29EDGAR2Form 8-K - Current report
09/12/202412:30BWEnanta Pharmaceuticals Announces Positive Topline Results..
06/12/202423:00BWEnanta Pharmaceuticals to Present Topline Results from..
04/12/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202414:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
25/11/202422:05EDGAR2Form 8-K - Current report
25/11/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
14/11/202422:03EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
17/10/202422:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
26/9/202412:00BWEnanta Pharmaceuticals Announces Positive Topline Results..
03/9/202413:00BWEnanta Pharmaceuticals to Participate in Investor..
09/8/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:05EDGAR2Form 8-K - Current report
05/8/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
15/7/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202423:30EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 6,83

La tua Cronologia

NASDAQ
ENTA
Enanta Pharmaceuticals
TSXV
ANCV.P
ANC Capital Ventures
USOTC
TYOBF
Toyobo (PK)
LSE
3SIS
Wt Silver 3x S
COIN
WINGBP
WINkLink
LSE
0QV2
Bactiguard Holding Ab
USOTC
KBCSF
KBC Group Sa Nv (PK)
NASDAQ
VERV
Verve Therapeutics
NASDAQ
CFLT
Confluent
USOTC
SPBBF
Speakeasy Cannabis Club (CE)
USOTC
TDRCF
Trinex Minerals (PK)
NASDAQ
FDTS
First Trust Developed Mk...
NASDAQ
IBAS
LSE
0R1B
Biogen
USOTC
ADRMF
Adherium (PK)
USOTC
MANVF
Manning Ventures (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci